Paper Details

  1. Home
  2. Paper Details

Effects of the use of AZT on the medical care costs of persons with AIDS in the first 12 months.

Author: AbramsD I, ClineM W, ScitovskyA A

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.

Overview

Azidothymidine (AZT) is a drug used to treat AIDS. This study compared medical care costs of AIDS patients who received AZT with those who did not. In the first 6 months, costs were lower for those using AZT due to less hospital use. However, costs rose in the second 6 months. The authors concluded that the lifetime costs of AIDS patients may be the same for those using or not using AZT.
Paper Details　
Original Abstract of the Article :
It is important in planning to meet resource needs and financing of care of people with acquired immune deficiency syndrome (AIDS) to determine the effect of the use of azidothymidine (AZT) on overall medical care costs. This study compares the medical care costs of people with AIDS (PWAs) who recei...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2384866

データ提供：米国国立医学図書館（NLM）

The Financial Landscape of AIDS Treatment

In the fight against AIDS, the use of azidothymidine (AZT) has revolutionized treatment, offering a beacon of hope in a seemingly insurmountable desert. This study investigates the impact of AZT on the medical care costs associated with AIDS, a critical aspect of resource allocation and healthcare planning. The researchers compared the medical care costs of individuals with AIDS (PWAs) who received AZT with those who did not, seeking to understand the financial implications of this groundbreaking therapy.

The Cost-Effectiveness of AZT

Their findings reveal that the use of AZT led to lower costs, primarily due to reduced hospitalizations, particularly in the initial six months of treatment. However, costs gradually increased during the second six months, suggesting that the long-term cost-effectiveness of AZT might be less pronounced. While the study did not conclusively prove a long-term cost reduction, it hinted at the potential cost-effectiveness of AZT, emphasizing the need for further research to fully understand the financial implications of this medication.

Navigating the Financial Realities of AIDS Treatment

This study highlights the importance of balancing cost-effectiveness with the potential benefits of new medications, particularly in the context of chronic illnesses like AIDS. The research serves as a guidepost for policymakers and healthcare providers, emphasizing the need for comprehensive cost-benefit analyses to ensure sustainable healthcare systems that effectively address the challenges of chronic diseases.

Dr. Camel's Conclusion

This study provides a fascinating glimpse into the financial landscape of AIDS treatment. While AZT offers a valuable therapeutic tool, its long-term cost-effectiveness remains an open question. It's a reminder that the fight against AIDS requires a multi-faceted approach, balancing the benefits of new treatments with the realities of resource allocation. As we continue to navigate the challenges of this complex disease, research like this guides us towards more sustainable and effective treatment strategies.
Date :
  1. Date Completed 1990-09-14
  2. Date Revised 2020-02-20
Further Info :

Pubmed ID

2384866

DOI: Digital Object Identifier

2384866

Related Literature

Article Analysis
・Effects of azt
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.